HAMILTON, ON, February 23, 2022 / – Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce it will be presenting at Gravitas’ 5th Annual Growth Conference taking place at the Fairmont Pacific Rim Hotel in Vancouver, British Columbia and also virtually on Thursday, March 3rd, 2022.
Dr. Lisa Crossley, CEO of Reliq Health Technologies is scheduled to present on Thursday, March 3rd, 2022, at 2:30pm PST. Dr. Crossley will also be fielding investor questions, hosting individual investor meetings and participating in a panel discussion at 10:00am PST during the one- day virtual and in-person conference hosted by Gravitas Securities Inc. “Gravitas’ 5th Annual Growth Conference represents an invaluable opportunity for Reliq to update shareholders on recent developments and to reach a broad audience of potential new investors in the US and Canada,” said Dr. Crossley. “As recently announced, Medicare’s expansion of its virtual care programs in 2022 to include Remote Therapeutic Monitoring has added an additional 20 Million newly eligible patients to Reliq’s target market, and we expect 2022 to be a year of unprecedented growth for the Company. I look forward to discussing the opportunities for Canadian companies doing business in the US with my fellow panel members, and to sharing the Reliq story with the conference attendees.”
Conference Details:
Event: Gravitas’ 5th Annual Growth Conference
Format: Presentations, Q&A, and Panel Discussion
Date: Thursday, March 3rd, 2022
Time: 8:00 AM PST – 5:30 PM PST
Venue: Held virtually, and in-person at the Fairmont Pacific Rim Hotel: 1038 Canada Place, Vancouver, BC, V6C 0B9
Registration: www.Gravitas5thAnnual.com
Reliq Health
Reliq Health Technologies is a rapidly growing global telemedicine that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the WKN as A2AJTB.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information please contact:
Company Contact
Investor Relations at ir@reliqhealth.com
US Investor Relations Contact
Investor Relations
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix
646-829-9701
shamsian@lythampartners.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.
We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Reliq Health Technologies Inc. (the “Company“) does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
